Protagonist Therapeutics (PTGX) Enters Securities Purchase Agreement for Up 2.75M Shares
Tweet Send to a Friend
Protagonist Therapeutics (NASDAQ: PTGX) disclosed in an SEC filing:On August 6, 2018, Protagonist Therapeutics, Inc. (the “Company”) entered into a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
